Market News
BioXcel Therapeutics (BTAI) Q4 loss widens on higher expenses
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) reported a wider net loss for the fourth quarter, owing to an increase in research and development expenses. Being a…